Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome

Published: 26 April 2024| Version 1 | DOI: 10.17632/hxv6jxmp2j.1
Contributor:
Jack Yanovski

Description

Underlying data presented in manuscript titled, "Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome"

Files

Steps to reproduce

See manuscript for analysis details.

Institutions

  • National Institute of Child Health and Human Development

Categories

Pharmacotherapy, Cholesterol, Body Weight, Body Fat Mass

Funders

  • Rhythm Pharmaceuticals

Licence